Overall, the data indicate that some ECIG flavors may result in the disruption of salivary mucin composition, which could lead to clinical manifestations such as xerostomia, oral microbial dysbiosis, periodontal disease, and others [95,115,116]. The gene discussed is MUC5AC; the disease is xerostomia.